Sandrock Alfred 4
4 · Voyager Therapeutics, Inc. · Filed Feb 26, 2026
Research Summary
AI-generated summary of this filing
Voyager Therapeutics (VYGR) CEO Alfred Sandrock Sells 14,197 Shares
What Happened
- Alfred Sandrock, President, CEO and Director of Voyager Therapeutics (VYGR), sold 14,197 shares on Feb 24, 2026. The weighted-average sale price was $3.79 per share for total proceeds of about $53,807. This was a sale (not a purchase) and appears to be a routine sell-to-cover for tax withholding related to vested restricted stock units.
Key Details
- Transaction date: 2026-02-24; Form 4 filed: 2026-02-26 (timely filing).
- Shares sold: 14,197; weighted-average price reported: $3.79; total proceeds: $53,807.
- Price range: shares were sold in multiple trades at prices from $3.61 to $3.86 (per filing footnote).
- Footnote: Sales were made under a durable automatic sale instruction (adopted May 12, 2025) to effect a sell-to-cover election to satisfy tax withholding for RSUs that vested Feb 21, 2026; the sales were not discretionary.
- Shares owned after the transaction: not specified in the summary provided.
Context
- This was a tax-withholding (sell-to-cover) sale tied to RSU vesting, a common executive action that typically reflects tax obligations rather than a directional bet on the stock. The filing indicates the trades were automated and non-discretionary per the reporting person’s instruction.
Insider Transaction Report
Form 4
Sandrock Alfred
DirectorPresident and CEO
Transactions
- Sale
Common Stock
[F1][F2]2026-02-24$3.79/sh−14,197$53,807→ 484,060 total
Footnotes (2)
- [F1]Represents shares of common stock of Voyager Therapeutics, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 21, 2026. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.86, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Signature
/s/ Gregory L. Shiferman, as Attorney-in-Fact for Alfred Sandrock|2026-02-26